Big Shoes to Fill at A Challenging Time
- PDF / 167,653 Bytes
- 2 Pages / 595.276 x 790.866 pts Page_size
- 96 Downloads / 176 Views
EDITORIAL
Big Shoes to Fill at A Challenging Time Tonglei Li 1
# Springer Science+Business Media, LLC, part of Springer Nature 2020
This is my first editorial as your editor-in-chief and I would like to take the opportunity to say thank you. Thank you to the leadership at the AAPS and Springer-Nature for the recognition and trust in me. Thank you to Dr. Peter Swaan and to Dr. Wolfgang Sadée for encouragement and help during the transition into this leadership role. And thank you to the readers, the authors, and the reviewers of Pharmaceutical Research for contributing in various ways to the journal over the last 35 years. I am looking forward to working with you all to drive this research forum to flourish continuously. This is a challenging time. As the pandemic has wreaked havoc on the world and put societies into a halt, we— pharmaceutical scientists—would feel more obliged in advancing science and drug treatment against this emerging and other complex diseases. This is also a changing time, much faster than before, in disseminating and sharing research findings. When this journal was founded in 1984, it would be mind-blowing to think of retrieving a research paper on a “smartphone.” The ease in submitting a manuscript to a large section of peer journals does seem to undermine the stature enjoyed by this journal for many years. Often, I heard from colleagues and students wondering about what is the focus of this journal. The vision of Pharmaceutical Research can still be best described by one of Dr. Wolfgang Sadée’s editorials in 1986 as “poised at the crossroads between the physicochemical sciences and the biological sciences” of drugs, diagnosis, and therapy [1]. It was later echoed by Dr. Vincent Lee in 2008 when he passed on the baton to Dr. Peter Swaan that the journal should serve the community by publishing papers that integrate “fundamental principles in chemistry, biology, and * Tonglei Li [email protected] 1
Department of Industrial & Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, IN 47907, USA
engineering for creating and evaluating” drug products and treatments [2]. What has also been instilled into the core of Pharmaceutical Research is publishing papers that are mechanism-based and hypothesis-driven. I share the vision and will work with my fellow editors to ensure this forum stays as a forerunner in serving the AAPS and the drug development community in general. As the business of pharmaceutical industry is mainly driven by innovation, traditional boundaries between drug development and discovery and clinical assessment become even more blurred, thanks to the advance and integration of individual disciplines, as well as exponential buildup in knowledge. The need for interdisciplinary research is more imperative, as drug products become more complex, multi-component, and even involve live cells or tissues. I hope Pharmaceutical Research will help promote research along this direction. A personal favorite with that regard is multiscale modeling and simulation in bri
Data Loading...
